{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:31:22Z","timestamp":1787776282611,"version":"build-2784847793"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>This study aims to comprehensively characterize the clinical, demographic, and histopathological features of ocular adnexal lymphoma (OAL) and assess their impact on patients\u2019 survival outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 123 patients were included in the study; of these, 93 patients were selected for survival analysis. Survival data were analyzed using the Kaplan-Meier test, and correlation was assessed through the log-rank test and Cox regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The median age at presentation was 56 years. Furthermore, 98% of patients had primary OAL. The orbit was the most common site of involvement. The majority of patients were of B-cell origin (98%), and only 2% of patients had T-cell lymphoma. In addition, 83% of patients were treated with chemotherapy, and with a median follow-up of 38 months, complete remission was achieved in 48% of patients. The median progression-free survival was 26.4 months. The presence of disseminated disease was strongly linked to an unfavorable prognosis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and reduced survival (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.037).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The 5-year overall survival of the entire study cohort was 81%. The prognosis for OAL is found to be favorable, but the presence of dissemination serves as a notable predictor for poor prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_110_24","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T10:00:29Z","timestamp":1735293629000},"page":"261-266","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Ocular adnexal lymphoma \u2013 A single-center observational study of survival outcomes"],"prefix":"10.4103","volume":"73","author":[{"given":"Karuvel Kannan","family":"Saraswathi","sequence":"first","affiliation":[{"name":"Department of Molecular Genetics, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India"},{"name":"Department of Molecular Biology, Aravind Medical Research Foundation - Affiliated to Alagappa University, Karaikudi, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragya","family":"Saini","sequence":"additional","affiliation":[{"name":"Department of Orbit, Oculoplasty, Ocular Oncology and Ocular Prosthesis, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Madurai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhakrishnan","family":"Santhi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Aravind Eye Hospital, Madurai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerappan","family":"Muthukkaruppan","sequence":"additional","affiliation":[{"name":"Department of Immunology and Stem Cell Biology, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayyasamy","family":"Vanniarajan","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India"},{"name":"Department of Molecular Biology, Aravind Medical Research Foundation - Affiliated to Alagappa University, Karaikudi, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Orbit, Oculoplasty, Ocular Oncology and Ocular Prosthesis, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Madurai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"R1-20250314","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3109\/01676830.2014.949789","article-title":"Profile of ocular and adnexal tumours at a tertiary institute of northeast India","volume":"33","author":"Das","year":"2014","journal-title":"Orbit"},{"key":"R3-20250314","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/jamaophthalmol.2015.6122","article-title":"Conjunctival lymphoma--An international multicenter retrospective study","volume":"134","author":"Kirkegaard","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"R4-20250314","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jamaophthalmol.2014.4644","article-title":"Ocular adnexal diffuse large B-cell lymphoma: A multicenter international study","volume":"133","author":"Munch-Petersen","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"R5-20250314","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00417-020-04896-1","article-title":"Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body","volume":"259","author":"Alfaar","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R6-20250314","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1038\/s41433-020-01198-y","article-title":"Orbital and ocular adnexal lymphoma: A review of epidemiology and prognostic factors in Taiwan","volume":"35","author":"Hsu","year":"2021","journal-title":"Eye (Lond)"},{"key":"R7-20250314","doi-asserted-by":"crossref","first-page":"132","DOI":"10.22608\/APO.2016209","article-title":"Lymphoproliferative tumors of the ocular adnexa","volume":"6","author":"Verdijk","year":"2017","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"R8-20250314","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3390\/cancers12092538","article-title":"Orbital and eyelid B-cell lymphoma: A multicenter retrospective study","volume":"12","author":"Savino","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R9-20250314","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.semdp.2015.10.004","article-title":"An update on ocular adnexal lymphoma","volume":"33","author":"Mulay","year":"2016","journal-title":"Semin Diagn Pathol"},{"key":"R11-20250314","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-9929.1000312","article-title":"Ocular adnexal lymphoma: Clinical presentation, diagnosis, treatment and prognosis","volume":"7","author":"Kamal","year":"2016","journal-title":"J Mol Biomark Diagn"},{"key":"R13-20250314","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.survophthal.2018.08.002","article-title":"Orbital lymphoma","volume":"64","author":"Olsen","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"R14-20250314","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.survophthal.2016.11.009","article-title":"Lymphoma of the eyelid","volume":"62","author":"Svendsen","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"R15-20250314","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.eye.6700379","article-title":"Clinical features associated with survival of patients with lymphoma of the ocular adnexa","volume":"17","author":"Jenkins","year":"2003","journal-title":"Eye (Lond)"},{"key":"R16-20250314","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/bjo.84.8.907","article-title":"Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival","volume":"84","author":"Jenkins","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R17-20250314","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajo.2017.02.004","article-title":"Lymphoma of the eyelid-An international multicenter retrospective study","volume":"177","author":"Svendsen","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R18-20250314","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ajo.2020.06.015","article-title":"Lymphoma of the lacrimal gland-An international multicenter retrospective study","volume":"219","author":"Vest","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"R20-20250314","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"R21-20250314","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ajo.2018.11.002","article-title":"Orbital lymphoma-an international multicenter retrospective study","volume":"199","author":"Olsen","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"R22-20250314","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bjophthalmol-2019-315637","article-title":"Ocular adnexal lymphoma in Denmark: A nationwide study of 387 cases from 1980 to 2017","volume":"105","author":"Holm","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"R23-20250314","first-page":"328","article-title":"Outcome and prognostic factors in ocular adnexal lymphoma","volume":"45","author":"Nola","year":"2004","journal-title":"Croat Med J"},{"key":"R24-20250314","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/IOP.0000000000002309","article-title":"Thirty years of experience with ocular adnexal T-cell lymphoma","volume":"39","author":"Manta","year":"2023","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R25-20250314","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/IOP.0b013e3181c53d23","article-title":"Primary T cell\/histiocyte-rich large B-cell lymphoma of the orbit","volume":"27","author":"Kim","year":"2011","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R26-20250314","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/IOP.0b013e31821cc4bb","article-title":"Primary, unilateral ocular adnexal lymphoma: Disease progression and long-term survival","volume":"27","author":"Rootman","year":"2011","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R27-20250314","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/bjophthalmol-2019-314008","article-title":"International multicentre retrospective cohort study of ocular adnexal marginal zone B-cell lymphoma","volume":"104","author":"Hindso","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R28-20250314","doi-asserted-by":"crossref","first-page":"769530","DOI":"10.3389\/fonc.2022.769530","article-title":"Long-term clinical outcomes in treatment-na\u00efve patients with orbital adnexal mucosa-associated lymphoid tissue lymphoma: A single-center study","volume":"12","author":"Min","year":"2022","journal-title":"Front Oncol"},{"key":"R29-20250314","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/bjophthalmol-2021-320466","article-title":"Specific location of ocular adnexal lymphoma and mortality: An international multicentre retrospective study","volume":"107","author":"Vest","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"R30-20250314","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s13244-012-0156-1","article-title":"Orbital lymphoma: Imaging features and differential diagnosis","volume":"3","author":"Priego","year":"2012","journal-title":"Insights Imaging"},{"key":"R31-20250314","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4103\/ijo.IJO_2773_20","article-title":"Acute orbital presentation in an activated B-cell subtype, diffuse large B-cell lymphoma: Clinicoradiological, histopathological and immunohistochemical correlation","volume":"1","author":"Tripathy","year":"2021","journal-title":"Indian J Ophthalmol Case Rep"},{"key":"R32-20250314","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jamaophthalmol.2017.4810","article-title":"Clinicopathological features of ocular adnexal mantle-cell lymphoma in an international multicenter cohort","volume":"135","author":"Knudsen","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"R33-20250314","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/IOP.0b013e3181bd436f","article-title":"Isolated optic nerve infiltration in systemic lymphoma--a case report and review of literature","volume":"26","author":"Kim","year":"2010","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R35-20250314","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/00006324-200109000-00008","article-title":"Non-Hodgkin\u2019s orbital lymphoma","volume":"78","author":"Lutz","year":"2001","journal-title":"Optom Vis Sci"},{"key":"R36-20250314","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0301-4738.81993","article-title":"Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type of the ocular adnexa: Retrospective single institution review of 95 patients","volume":"59","author":"Lim","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"R37-20250314","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/annonc\/mdm457","article-title":"Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma","volume":"19","author":"Song","year":"2008","journal-title":"Ann Oncol"},{"key":"R38-20250314","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamaophthalmol.2014.376","article-title":"Ocular adnexal follicular lymphoma: A multicenter international study","volume":"132","author":"Rasmussen","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"R39-20250314","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2147\/OPTH.S5828","article-title":"Treatment options for ocular adnexal lymphoma (OAL)","volume":"3","author":"Cohen","year":"2009","journal-title":"Clin Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_110_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:02:48Z","timestamp":1787774568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_110_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_110_24","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"2024-01-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}